Related Experiment Video
Updated: Aug 5, 2026

Investigating Mast Cell Secretory Granules; from Biosynthesis to Exocytosis
Published on: January 26, 2015
Prostaglandin E2 promotes degranulation-independent release of MCP-1 from mast cells
Takayuki Nakayama1, Noriko Mutsuga, Lei Yao
1Experimental Transplantation and Immunology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland 20892, USA. Nakayamt@mail.nih.gov
Abstract:
Mast cells (MCs) are common components of inflammatory infiltrates and a source of proangiogenic factors. Inflammation is often accompanied by vascular changes. However, little is known about modulation of MC-derived proangiogenic factors during inflammation. In this study, we evaluated the effects of the proinflammatory mediator prostaglandin E2 (PGE2) on MC expression and release of proangiogenic factors. We report that PGE2 dose-dependently induces primary MCs to release the proangiogenic chemokine monocyte chemoattractant protein-1 (MCP-1). This release of MCP-1 is complete by 2 h after PGE2 exposure, reaches levels of MCP-1 at least 15-fold higher than background, and is not accompanied by degranulation or increased MCP-1 gene expression. By immunoelectron microscopy, MCP-1 is detected within MCs at a cytoplasmic location distinct from the secretory granules. Dexamethasone and cyclosporine A inhibit PGE2-induced MCP-1 secretion by approximately 60%. Agonists of PGE2 receptor subtypes revealed that the EP1 and EP3 receptors can independently mediate MCP-1 release from MCs. These observations identify PGE2-induced MCP-1 release from MCs as a pathway underlying inflammation-associated angiogenesis and extend current understanding of the activities of PGE2.
Insights
Prostaglandin E2 (PGE2) triggers mast cells to release monocyte chemoattractant protein-1 (MCP-1), a key factor in inflammation-associated angiogenesis. This release occurs rapidly without degranulation, highlighting a novel pathway in vascular changes during inflammation.
Area of Science:
- Immunology
- Cell Biology
- Angiogenesis Research
Background:
- Mast cells (MCs) are integral to inflammatory responses and contribute proangiogenic factors.
- Vascular changes frequently accompany inflammation, yet the regulation of MC-derived proangiogenic factors remains unclear.
Purpose of the Study:
- To investigate the impact of the inflammatory mediator prostaglandin E2 (PGE2) on the expression and release of proangiogenic factors from mast cells.
Main Methods:
- Primary mast cells were exposed to varying concentrations of PGE2.
- Monocyte chemoattractant protein-1 (MCP-1) release was quantified over time.
- Immunoelectron microscopy was used to localize MCP-1 within mast cells.
- The effects of dexamethasone, cyclosporine A, and PGE2 receptor subtype agonists were assessed.
Main Results:
- PGE2 dose-dependently induced MCP-1 release from mast cells, with significant levels observed within 2 hours.
- MCP-1 release was independent of mast cell degranulation or increased MCP-1 gene expression.
- Immunoelectron microscopy revealed MCP-1 localized in the cytoplasm, separate from secretory granules.
- Dexamethasone and cyclosporine A inhibited PGE2-induced MCP-1 secretion by approximately 60%.
- EP1 and EP3 prostaglandin E2 receptor subtypes were identified as mediators of MCP-1 release.
Conclusions:
- PGE2-induced MCP-1 release from mast cells represents a significant pathway contributing to inflammation-associated angiogenesis.
- This mechanism expands the understanding of prostaglandin E2's biological activities and its role in inflammatory vascular remodeling.
Related Concept Videos
Inflammation
Differentiation of Common Myeloid Progenitor Cells
IP3/DAG Signaling Pathway
Role of Matrix Metalloproteases in Degradation of ECM
A...

